Navigation Links
Labopharm Reports Results for Third Quarter Fiscal 2009
Date:11/6/2009

or $0.46 per share, for the first nine months of fiscal 2008. The decrease in net loss is primarily the result of lower research and development costs, a higher foreign exchange gain and the absence of an impairment loss, which were partially offset by higher selling, general and administrative expenses and lower interest income in the first nine months of fiscal 2009 as compared to the same period the previous year.

Conference Call

Labopharm will host a conference call today (Friday, November 6, 2009) at 10:00 a.m. ET to discuss its third quarter results. To access the conference call by telephone, dial 416-644-3422 or 1-877-974-0448. Please connect approximately five minutes prior to the beginning of the call to ensure participation. The conference call will be archived for replay until Friday, November 13, 2009 at midnight. To access the archived conference call, dial 416-640-1917 or 1-877-289-8525 and enter the reservation number 4171872 followed by the number sign. A live audio webcast of the conference call will be available at www.labopharm.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above web site for 30 days.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. and Canada. The Company also has a pipeline of follow-on products in both pre-clinical and clinical development.
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
2. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
3. Labopharm submits response to FDA for novel antidepressant
4. Labopharm Reports Results for Second Quarter Fiscal 2009
5. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
6. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
7. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
8. Labopharm amends debt facility agreement with Hercules
9. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
10. Labopharm Reports Results for First Quarter Fiscal 2009
11. Labopharm announces details for first quarter results conference call and annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Active Aging Week is a week-long observance ... members of society and promotes the benefits of leading ... a boutique retirement community located at 1200 Overlook Drive, ... of Cyber-Seniors - a humorous and heartwarming documentary. , ... this great film,” says Thomas Cloutier, Executive Director for ...
(Date:9/18/2014)... September 18, 2014 Alexandria, VA — ... today that 10 more communities have joined the growing ... health department accreditation. The decisions bring the number of ... 54. PHAB is the non-profit organization that administers the ... and protect the health of the public by advancing ...
(Date:9/18/2014)... Reinberg HealthDay Reporter , THURSDAY, Sept. ... outbreak in West Africa is starting to spread faster than ever, ... cases of the deadly viral infection were reported in just one ... than 5,300, with roughly half of those reported in the past ... deaths now tops 2,600. WHO has estimated that as many ...
(Date:9/18/2014)... CA (PRWEB) September 18, 2014 Companies ... and refine carbon dioxide, selling it to downstream industries ... markets for carbon dioxide are food and beverage manufacturers. ... such as fruits, vegetables or pizzas. The gas is ... manufacturers use the compound to carbonate soft drinks, beer ...
(Date:9/18/2014)... exercise is good for you. But new research from ... an added benefit for cancer patients undergoing chemotherapy. , ... found that combining exercise with chemotherapy shrunk tumors more ... professor in the School of Nursing and director of ... the senior author on the study, which appears in ...
Breaking Medicine News(10 mins):Health News:In Support of Active Aging Week, a Lake Oswego Retirement Community Will Get a Sneak Peek at an Inter-Generational Documentary – Cyber-Seniors 2Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2
... medical center,s dramatic growth and steady ... over nearly four decades, GLEN BURNIE, Md., Sept. 18 ... those as president and CEO,James R. Walker has announced his ... night at the BWMC Board of Directors meeting. (Photo: ...
... Expanded leave,benefits for military families is a ... to balance the needs of employees and employers, ... the world,s largest,association of human resource professionals., ... for members of the,National Guard, Reservists and their ...
... Quality Forum (NQF) and The Joint Commission today announced the,2007 ... Quality,Awards. Honorees were selected in all four award categories., ... ACHIEVEMENT (2 RECIPIENTS), -- Flaura Koplin Winston, M.D., Ph.D. ... Prevention at The Children,s Hospital of Philadelphia and the ...
... is quiet almost too quiet in movies, it is ... good guys. This holds true for the genes that protect against ... Ohio, have learned. They identified a panel of 15 genes that ... becomes quiet almost too quiet -- it could mean they ...
... In an 18-year-study on attention-deficit hyperactivity disorder (ADHD), ... stimulants is associated with improved long-term academic success ... are the first population-based data to show stimulant ... A related Mayo Clinic study reveals that compared ...
... study finds , , TUESDAY, Sept. 18 (HealthDay News) -- ... by looking at Web sites can leave would-be patients ... study finds. , In looking over six hospital-comparison Web ... inappropriate or incomplete standards to measure a center,s quality, ...
Cached Medicine News:Health News:BWMC President and CEO Announces Retirement 2Health News:BWMC President and CEO Announces Retirement 3Health News:SHRM Testimony Urges Congress to Fix FMLA 2Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 2Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 3Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 4Health News:2007 John M. Eisenberg Patient Safety and Quality Award Recipients Announced 5Health News:Test for lung cancer looks for discomforting quiet among protective genes 2Health News:Test for lung cancer looks for discomforting quiet among protective genes 3Health News:Mayo Clinic study indicates medication for ADHD may help student outcomes 2Health News:Mayo Clinic study indicates medication for ADHD may help student outcomes 3Health News:Hospital Quality Info on Web Can Be Misleading 2Health News:Hospital Quality Info on Web Can Be Misleading 3
(Date:9/18/2014)... SAN DIEGO , Sept. 18, 2014 /PRNewswire/ ... today announced that the U.S. Food and Drug ... patient enrollment and dosing of PEGPH20 in SWOG,s ... is designed to evaluate Halozyme,s investigational drug PEGPH20 ... FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic ...
(Date:9/18/2014)... After 6 months of careful research with the ... new programme for the next Cool Chain & Temperature Controlled ... Chain series, has just been released! You can ... lines between supply chain, logistics, QA and purchasing continue to ... and yet specific, focused and yet accessible, inclusive and targeted ...
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... oncology electronic medical record (EMR) – the ... certification under the HITECH Act – has propelled Elekta ... / hematology EMR vendors in the annual Black Book ... a "comprehensive ambulatory EMR vendor" were: electronic health records ...
... Therapeutics, Inc. (OTCBB: ECTE), a company developing its ... transdermal continuous glucose monitoring system and its Prelude™ ... that Patrick T. Mooney, M.D., CEO, President and ... present at the Jefferies 2011 Global Healthcare Conference. ...
Cached Medicine Technology:Elekta's MOSAIQ Far Ahead of Contenders in Black Book Rankings User Survey of EMR Vendors 2Elekta's MOSAIQ Far Ahead of Contenders in Black Book Rankings User Survey of EMR Vendors 3
... suspension in methanol for faster, more ... histology smears. Our special manufacturing process ... cellular elements producing unequaled definition of ... unexcelled brilliance in the resulting smear. ...
... ideal for stat, routine or back-up staining. ... seconds) and bone marrow (20-30 seconds). Our ... particles which yield excellent color intensity and ... steps involved in the Wright's staining procedure ...
... fast, single-solution staining, Hema-Quik II ... slides into stain solution for ... to deionized water for five ... second time by dipping quickly ...
... Stain is ideal for stat, routine or ... smears and bone marrow. Our unique manufacturing ... yield excellent color intensity and morphological differentiation. ... in the Wright's staining procedure and includes ...
Medicine Products: